Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility Aug 3, 2023
Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow May 18, 2023
Kane Biotech Announces Distribution Agreement with ProgenaCare Global for its coactiv+™ Antimicrobial Wound Gel Apr 20, 2023
Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow Apr 13, 2023
